Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lymphocytes, Tumor-Infiltrating"" wg kryterium: Temat


Tytuł:
Prognostic value of CD103 tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma.
Autorzy:
Smith JD; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Bellile EL; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, United States.
Ellsperman SE; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Heft-Neal ME; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Mann JE; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, United States.
Birkeland AC; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Hoesli RC; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Swiecicki PL; Division of Hematology & Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, United States; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, United States.
Worden FP; Division of Hematology & Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, United States; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, United States.
Schonewolf C; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, United States.
Shah JL; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, United States.
Mierzwa ML; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, United States.
Rosko AJ; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Stucken CL; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Chinn SB; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, United States.
Shuman AG; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Casper KA; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Malloy KM; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Prince MEP; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Wolf GT; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States.
Thomas DG; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, United States.
McHugh JB; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, United States.
Chad Brenner J; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, United States; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, United States.
Spector ME; Department of Otolaryngology - Head & Neck Surgery, University of Michigan, Ann Arbor, MI 48109, United States; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, United States. Electronic address: .
Pokaż więcej
Źródło:
Oral oncology [Oral Oncol] 2022 Dec; Vol. 135, pp. 106226. Date of Electronic Publication: 2022 Oct 28.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Head and Neck Neoplasms*/pathology
Humans ; B7-H1 Antigen ; Prognosis ; Squamous Cell Carcinoma of Head and Neck/pathology ; Retrospective Studies ; Biomarkers, Tumor
Czasopismo naukowe
Tytuł:
Predictive value of tumor-infiltrating lymphocytes detected by flow cytometry in colorectal cancer.
Autorzy:
Hu Y; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China.
Zhao J; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China; Department of Microbiology and Immunology, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Shen Y; Central Laboratory, Suzhou Ninth People's Hospital, Suzhou, China.
Zhang C; Center of Repository, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Xia Q; Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Zhang G; Department of General Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Wang B; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China.
Wei B; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Yu R; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address: .
Ma J; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China; Center of Repository, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: .
Guo Y; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2022 Dec; Vol. 113 (Pt A), pp. 109286. Date of Electronic Publication: 2022 Oct 15.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Colorectal Neoplasms*/pathology
Humans ; Flow Cytometry ; CD8-Positive T-Lymphocytes ; Kaplan-Meier Estimate ; Biomarkers/metabolism ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker.
Autorzy:
Bell PD; Department of Pathology, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.
Pai RK; Department of Pathology, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Dec; Vol. 81 (6), pp. 696-714. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Colorectal Neoplasms*/pathology
Humans ; Prognosis ; Lymphocyte Count ; Immunity ; CD8-Positive T-Lymphocytes
Czasopismo naukowe
Tytuł:
Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer.
Autorzy:
Zhu Y; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China.
Zhou J; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China.
Zhu L; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China.
Hu W; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China.
Liu B; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China.
Xie L; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (5), pp. 2060019. Date of Electronic Publication: 2022 Apr 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Uterine Cervical Neoplasms*/pathology
Uterine Cervical Neoplasms*/therapy
Cell- and Tissue-Based Therapy ; Female ; Humans ; Immunotherapy, Adoptive/adverse effects
Czasopismo naukowe
Tytuł:
Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients.
Autorzy:
Vaid PM; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Department of Biological Sciences, Ashoka University, Sonipat, India.
Puntambekar AK; Pathology Department, Ruby Hall Clinic, Pune, India.
Jumle NS; Department of Pathology, Jehangir Hospital, Pune, India.
Banale RA; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Ansari D; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Reddy RR; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Unde RR; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Namewar NP; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Kelkar DA; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Shashidhara LS; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Department of Biological Sciences, Ashoka University, Sonipat, India.; Indian Institute of Science Education and Research, Pune, India.
Koppiker CB; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Kulkarni MD; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India. .; Prashanti Cancer Care Mission, Pune, Maharashtra, India. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2022 Nov 21; Vol. 17 (1), pp. 91. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Triple Negative Breast Neoplasms*/pathology
Humans ; Retrospective Studies ; Prognosis
Czasopismo naukowe
Tytuł:
Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes.
Autorzy:
Li CY; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Park HJ; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Shin J; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Baik JE; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Mehrara BJ; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Kataru RP; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Nov 03; Vol. 23 (21). Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Melanoma*/metabolism
Mice ; Humans ; Animals ; Endothelial Cells/metabolism ; Antigen Presentation ; CD8-Positive T-Lymphocytes ; Antigens, Neoplasm/metabolism ; Mice, Transgenic ; Histocompatibility Antigens Class II/metabolism ; CD4-Positive T-Lymphocytes ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade.
Autorzy:
Santinon F; Département de Médecine, Université de Montréal, Montréal, QC, H3C 3J7, Canada.; Division of Immunology-Oncology, Centre de Recherche Hopital Maisonneuve-Rosemont, Montréal, QC, H1T 2M4, Canada.
Ezzahra BF; Division of Immunology-Oncology, Centre de Recherche Hopital Maisonneuve-Rosemont, Montréal, QC, H1T 2M4, Canada.
Bachais M; Département de Médecine, Université de Montréal, Montréal, QC, H3C 3J7, Canada.; Division of Immunology-Oncology, Centre de Recherche Hopital Maisonneuve-Rosemont, Montréal, QC, H1T 2M4, Canada.
Sarabia Pacis A; Canadian Centre for Computational Genomics, McGill University, Montréal, QC, H3A 0G1, Canada.
Rudd CE; Département de Médecine, Université de Montréal, Montréal, QC, H3C 3J7, Canada. .; Canadian Centre for Computational Genomics, McGill University, Montréal, QC, H3A 0G1, Canada. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 02; Vol. 12 (1), pp. 18509. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Neoplasms*/pathology
Humans ; Programmed Cell Death 1 Receptor/metabolism ; Interferon-gamma/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; CD8-Positive T-Lymphocytes
Czasopismo naukowe
Tytuł:
Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor-infiltrating lymphocyte levels.
Autorzy:
Ugai T; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Liu L; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology and Biostatistics, and the Ministry of Education Key Lab of Environment and Health, School of Public Health, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.; Hubei Cancer Hospital Wuhan, Hubei, P.R. China.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Tabung FK; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
Hamada T; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Langworthy BW; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Akimoto N; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Haruki K; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Takashima Y; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Okadome K; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Kawamura H; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Zhao M; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Kahaki SMM; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Glickman JN; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Lennerz JK; Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Zhang X; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Chan AT; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Fuchs CS; Genentech, South San Francisco, California, USA.
Song M; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Wang M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Yu KH; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Nowak JA; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Wu K; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Ogino S; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Cancer Immunology Program, Dana-Farber / Harvard Cancer Center, Boston, Massachusetts, USA.
Giovannucci EL; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2022 Nov; Vol. 12 (11), pp. e1114.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/pathology
Humans ; Prognosis ; Follow-Up Studies ; Diet/adverse effects
Czasopismo naukowe
Tytuł:
Patterns of immune infiltration and survival in endocrine therapy-treated ER-positive breast cancer: A computational study of 1900 patients.
Autorzy:
Wang WQ; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China.
Zhang L; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China.
Yang F; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha 410078, Hunan, PR China.
Zhou HH; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China.
Zhang W; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China.
Zou Y; School of Information Science and Engineering, Central South University, ChangSha 410083, PR China; Information and Network Center, Central South University, Changsha 410083, PR China. Electronic address: .
Liu R; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, PR China; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, PR China. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Nov; Vol. 155, pp. 113787. Date of Electronic Publication: 2022 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Neoplasm Recurrence, Local*/pathology
Humans ; Tumor Microenvironment ; Macrophages/metabolism ; CD4-Positive T-Lymphocytes
Czasopismo naukowe
Tytuł:
Correlation between IFNAR1 expression in peripheral blood T lymphocytes and inflammatory cytokines, tumor-infiltrating lymphocytes, and chemosensitivity in patients with colorectal cancer.
Autorzy:
Yang L; Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Zhang X; Department of Oncology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Huang X; Medical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Dong X; Medical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Jing S; Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Zhang Y; Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Zhao B; Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: .
Wang Z; Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: .
Qu H; Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: .
Pokaż więcej
Źródło:
Cytokine [Cytokine] 2022 Nov; Vol. 159, pp. 156008. Date of Electronic Publication: 2022 Sep 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Neoplasms*/metabolism
Lymphocytes, Tumor-Infiltrating*
CD4-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; Cytokines/metabolism ; Humans ; Interleukin-2/metabolism ; Interleukin-6/metabolism ; Receptor, Interferon alpha-beta/metabolism ; Tumor Microenvironment ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł:
Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma.
Autorzy:
Esmeray Sönmez E; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.
Hatipoğlu T; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.
Kurşun D; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.
Hu X; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.
Akman B; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.
Yuan H; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Department of Basic Oncology, Oncology Institute, Dokuz Eylül University, İzmir 35340, Türkiye.
Erşen Danyeli A; Department of Pathology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.; Department of Pathology, Acıbadem University Altunizade Hospital, İstanbul 34662, Türkiye.
Alacacıoğlu İ; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
Özkal S; Department of Pathology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
Olgun A; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.; İzmir Tepecik Research and Training Hospital, Health Sciences University, İzmir 35020, Türkiye.
Erdağ TK; Department of Otorhinolaryngology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
You H; Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, Department of Hematology and Oncology, Children's Hospital of Chongqing Medical University, Chongqing 401122, China.; International Science and Technology Cooperation Base of Child Development and Critical Disorders, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing 401122, China.
Küçük C; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.; Department of Medical Biology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Oct 27; Vol. 11 (21). Date of Electronic Publication: 2022 Oct 27.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, Mantle-Cell*/genetics
RNA, Long Noncoding*/genetics
Lymphocytes, Tumor-Infiltrating*/metabolism
Adult ; Humans ; Carcinogenesis ; CD8-Positive T-Lymphocytes/metabolism ; RNA, Messenger/genetics ; von Willebrand Factor ; Whole Exome Sequencing ; Biomarkers, Tumor/genetics ; Prognosis
Czasopismo naukowe
Tytuł:
Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
Autorzy:
Li B; Georgia Cancer Center and Department of Pediatrics, Medical College at Georgia (GA), Augusta, GA, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Oct 21; Vol. 13, pp. 973881. Date of Electronic Publication: 2022 Oct 21 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Melanoma*
Humans ; Immunotherapy ; Lymphocytes/pathology ; Lymphocyte Count
Czasopismo naukowe
Tytuł:
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
Autorzy:
Mollavelioglu B; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Cetin Aktas E; Department of Immunology, Istanbul University, Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.
Cabioglu N; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Abbasov A; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Onder S; Department of Pathology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.
Emiroglu S; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Tükenmez M; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Muslumanoglu M; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Igci A; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Deniz G; Department of Immunology, Istanbul University, Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.
Ozmen V; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2022 Oct 21; Vol. 20 (1), pp. 349. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Breast Neoplasms*/pathology
Humans ; Female ; CTLA-4 Antigen ; Hepatitis A Virus Cellular Receptor 2/metabolism ; Programmed Cell Death 1 Receptor ; Ki-67 Antigen/metabolism ; Receptors, Immunologic/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors.
Autorzy:
John J; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Woolaver RA; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, United States.
Popolizio V; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, United States.
Chen SMY; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, United States.
Ge H; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Krinsky AL; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, United States.
Vashisht M; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Kramer Y; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, United States.
Chen Z; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Wang JH; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Oct 18; Vol. 13, pp. 992630. Date of Electronic Publication: 2022 Oct 18 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Carcinoma, Squamous Cell*
Mice ; Animals ; CD8-Positive T-Lymphocytes ; Lymphocyte Activation ; Receptors, Antigen, T-Cell/genetics
Czasopismo naukowe
Tytuł:
Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.
Autorzy:
Su GH; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, No. 270 Dong'an Road, Shanghai, 200032, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Xiao Y; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, No. 270 Dong'an Road, Shanghai, 200032, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Jiang L; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, No. 270 Dong'an Road, Shanghai, 200032, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Zheng RC; Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, 201203, China.
Wang H; Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, 201203, China.
Chen Y; Division of Cancer and Stem Cell, School of Medicine at University of Nottingham, Nottingham, UK.
Gu YJ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .; Department of Radiology, Fudan University Shanghai Cancer Center, No. 270 Dong'an Road, Shanghai, 200032, People's Republic of China. .
You C; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .; Department of Radiology, Fudan University Shanghai Cancer Center, No. 270 Dong'an Road, Shanghai, 200032, People's Republic of China. .
Shao ZM; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, No. 270 Dong'an Road, Shanghai, 200032, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2022 Oct 15; Vol. 20 (1), pp. 471. Date of Electronic Publication: 2022 Oct 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Triple Negative Breast Neoplasms*/diagnostic imaging
Triple Negative Breast Neoplasms*/genetics
CD8-Positive T-Lymphocytes ; Cytokines/metabolism ; Humans ; Retrospective Studies ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Tumor infiltrating lymphocytes profile and response in neoadjuvant chemotherapy-treated triple-negative breast carcinoma patients.
Autorzy:
Ray D; Department of Pathology, Medical College and Hospital, Kolkata, West Bengal, India.
Gupta SD; Department of Pathology, Medical College and Hospital, Kolkata, West Bengal, India.
De A; Department of Hepatology, PGIMER, Chandigarh, India.
Jain P; Department of Pathology, Medical College and Hospital, Kolkata, West Bengal, India.
Bhattacharya NK; Department of Pathology, Medical College and Hospital, Kolkata, West Bengal, India.
Biswas PK; Department of Pathology, Medical College and Hospital, Kolkata, West Bengal, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Oct-Dec; Vol. 18 (6), pp. 1782-1788.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/metabolism
Triple Negative Breast Neoplasms*/pathology
Humans ; Adult ; Middle Aged ; Neoadjuvant Therapy ; Prognosis
Czasopismo naukowe
Tytuł:
Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes.
Autorzy:
Zhang C; Laboratory of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Sun Y; Laboratory of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Li S; Laboratory of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Shen L; Laboratory of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Teng X; Laboratory of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Xiao Y; Laboratory of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Wu N; Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China .
Lu Z; Laboratory of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China .
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Oct; Vol. 10 (10).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/metabolism
Neoplasms*/metabolism
Humans ; Spermidine/metabolism ; Spermidine/pharmacology ; Immunotherapy, Adoptive/methods ; Receptors, Antigen, T-Cell/metabolism ; Autophagy
Czasopismo naukowe
Tytuł:
The tumor-infiltrating lymphocyte ultrasonography score can provide a diagnostic prediction of lymphocyte-predominant breast cancer preoperatively.
Autorzy:
Kanou A; Division of Laboratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Masumoto N; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-0037, Japan. .
Fukui K; Division of Laboratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Yokozaki M; Division of Laboratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Sasada S; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-0037, Japan.
Emi A; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-0037, Japan.
Kadoya T; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-0037, Japan.
Arihiro K; Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan.
Okada M; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-0037, Japan.
Pokaż więcej
Źródło:
Journal of medical ultrasonics (2001) [J Med Ultrason (2001)] 2022 Oct; Vol. 49 (4), pp. 709-717. Date of Electronic Publication: 2022 Aug 24.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/surgery
Breast Neoplasms*/pathology
Humans ; Female ; Lymphocytes/pathology ; ROC Curve ; Ultrasonography ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Characteristics of tumor infiltrating lymphocytes in sinonasal mucosal melanoma and prognosis for patients.
Autorzy:
Yin G; Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Guo W; Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Liu H; Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Huang Z; Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Electronic address: .
Chen X; Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Electronic address: .
Pokaż więcej
Źródło:
Current problems in cancer [Curr Probl Cancer] 2022 Aug; Vol. 46 (4), pp. 100878. Date of Electronic Publication: 2022 Jun 11.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/metabolism
Lymphocytes, Tumor-Infiltrating*/pathology
Melanoma*/pathology
CD8-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/pathology ; Humans ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling.
Autorzy:
Fix SM; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Forget MA; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sakellariou-Thompson D; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wang Y; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Griffiths TM; Biologics Development, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lee M; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Haymaker CL; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Dominguez AL; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Basar R; Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Reyes C; Cell Biology R&D, Thermo Fisher Scientific, Carlsbad, California, USA.
Kumar S; Cell Biology R&D, Thermo Fisher Scientific, Carlsbad, California, USA.
Meyer LA; Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hwu P; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA .
Bernatchez C; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jazaeri AA; Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jul; Vol. 10 (7).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Ovarian Neoplasms*/therapy
Carcinoma, Ovarian Epithelial/pathology ; Female ; Humans ; Immunotherapy, Adoptive/methods ; Receptor, Transforming Growth Factor-beta Type II/genetics ; Transforming Growth Factor beta/genetics ; Tumor Microenvironment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz